Conditioning Agent
S-HIV-1 OLIGOPEPTIDE-7 SH-OLIGOPEPTIDE-1 SP
Safety score · 0–100
Moderate
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
A synthetic fusion peptide combining an HIV-derived sequence with a human growth factor peptide — designed for skin conditioning and protection.
This 76-amino-acid synthetic peptide fuses s-HIV-1 Oligopeptide-7 (derived from HIV-1 protein sequences) with sh-Oligopeptide-1 SP (human EGF-like peptide). The HIV-derived sequence is a small, non-infectious fragment repurposed for its cell-penetrating properties. While the peptide itself carries no viral risk, the HIV-derived nomenclature raises consumer perception concerns. Limited independent safety data available.
Function
Skin benefits
- skin conditioning
- skin protection
- cell-penetrating delivery
Known concerns
- HIV-derived sequence nomenclature
- very limited safety data
- novel and unusual peptide construct
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Related conditioning agents
Check your shelf
Find S-HIV-1 OLIGOPEPTIDE-7 SH-OLIGOPEPTIDE-1 SP in your products.
Scan any cosmetic product with LuxSense to see if it contains S-HIV-1 OLIGOPEPTIDE-7 SH-OLIGOPEPTIDE-1 SP and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.